Indefinite Delivery Contract W81XWH18D0027

The National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, awarded a single award Indefinite Delivery Contract to Alchem Laboratories Corporation. The contract has a potential value of $7,777,665 and a period of performance from September 2017 to September 2022. Under the contract, Alchem Laboratories Corporation provides non-good manufacturing practices synthesis of small molecules to support the National Cancer Institute's...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) valued up to $17,887,012 to Organix Chemistry Solutions LLC for CRO Support for NCATS Medicinal Chemistry for Lead Optimization. Under this multiple-award IDC, Organix was issued two delivery orders to date. The first delivery order, valued at $3,677,412.09, provides synthetic chemistry support services to NCATS'...

This is an indefinite-delivery/indefinite-quantity (IDIQ) contract awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Bachem Americas, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical ingredients. The contract, valued up to $49.7M, is for Chemistry, Manufacturing, and Controls (CMC) services to support NCATS' drug development programs, including the production of active...

The Department of Health and Human Services' National Center for Advancing Translational Sciences (NCATS) has issued a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at up to $49,885,703 to support Chemistry, Manufacturing, and Control (CMC) services for drug product development. The 7-year contract was awarded to Fisher Bioservices Inc.'s Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract scope includes a wide range of CMC services...

The Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) has awarded a single-award indefinite delivery contract to Polypeptide Laboratories San Diego, LLC, a Contract Development & Manufacturing Organization (CDMO), to provide chemistry, manufacturing, and controls (CMC) services for the development of drug substances. This five-year, $49.7 million IDV contract, awarded without set-asides, supports NCATS'...

The U.S. National Center for Advancing Translational Sciences (NCATS) has awarded an indefinite delivery contract (IDC) with a ceiling value of $49,885,703.00 to Purdue University to provide Chemistry, Manufacturing, and Control (CMC) services for the development of drug products. This multiple-award contract has an ultimate completion date of July 31, 2031. The scope of the contract includes a broad range of preclinical services required for the design, development, manufacture, and release...

Alchem Laboratories Corporation was awarded a single award indefinite delivery contract by the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services. The contract has a potential value of $12,069,385 and a period of performance through April 10, 2028. The contract aims to procure analysis and synthesis of Good Manufacturing Practice and non-GMP bulk drugs and pharmaceutical formulations to support the National Cancer Institute's...

This indefinite delivery contract was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Mriglobal, a 501(c)(3) not-for-profit research organization, with a potential value of $49,713,679. The contract is for Chemistry, Manufacturing and Controls (CMC) and related services to support the development of drug substances for the Division of Preclinical Innovation's translational research programs. The contract...

The key products and services being delivered under this federal contract IDV award from the National Cancer Institute (NCI) are preclinical toxicology studies on small molecule drug candidates for cancer and other indications. The prime contractor, IIT Research Institute (IITRI), a division of the Illinois Institute of Technology, will conduct non-GLP and GLP toxicology assessments in mice and dogs to support Investigational New Drug (IND) applications. IITRI holds several significant IDIQ...

This indefinite delivery contract (IDC), awarded by the National Institutes of Health National Institute on Drug Abuse (NIDA) to Vitae Enim Vitae Scientific, Inc. (VEV Scientific), provides Chemistry, Manufacturing, and Control (CMC) services to support the development of drug products by the National Center for Advancing Translational Sciences (NCATS). The $49.9M, 7-year contract will deliver a range of preclinical services required for the design, development, manufacture, and release of...